CANADA CLINICAL NUTRITION MARKET ANALYSIS

The Canada Clinical Nutrition Market is estimated to be valued at US$ 642.9 million in 2023 and is expected to exhibit a CAGR of 5.4% during the forecast period (2023-2030).

Analysts’ Views on Canada Clinical Nutrition Market:

The Canada clinical nutrition market is showing prominent growth due to many reasons, such as the increasing prevalence of chronic diseases among the population, the rising geriatric population, increasing research and development activities for the production of innovative clinical nutrition products etc. The aging population in Canada is a major driver of growth for the Canada clinical nutrition market. According to Health Canada 2020, Canada has one of the highest proportions of elderly citizens in the world, with almost 18% of its population aged 65 and older, according to Statistics Canada. The aging population is expected to significantly drive up demand for healthcare and medical nutrition products in the coming years.

Figure 1. Canada Clinical Nutrition Market Share (%), By Nutrition Type, 2023

To learn more about this report, request sample copy

Canada Clinical Nutrition Market– Drivers

• Increasing Awareness about the Nutrition Among Canadian Population: Due to the increase in awareness about nutrition among the Canadian population, there has been a growing demand for clinical nutrition among the population. This is expected to drive the growth of the Canada clinical nutrition market over the forecast period. For instance, since COVID-19 pandemic, awareness about the importance of proper nutrition and its impact on health has grown significantly among Canadians. More patients and healthcare providers now recognize that dietary modifications and nutrition interventions play a crucial role in treatment and management of chronic diseases. This growing recognition has fueled greater demand for specialized clinical nutrition products and services. For example, according to the research article published in the journal Healthcare 2022, as per the survey carried out by Dietitians of Canada, in the year 2021, it was found that over 80% of Canadians believe nutrition is important for disease prevention and management, compared to just 60% five years ago. As knowledge increases, consumers and doctors are more willing to utilize personalized nutritional therapies for conditions like diabetes, obesity, cardiovascular issues, and gastrointestinal disorders.
• Increasing Acquisition by the Market Players: Market players are focused on inorganic growth strategies, such as signing acquisition agreements, in order to expand its product portfolio and geographical presence in the market. In February 2022, Nestle Health Science, a provider of nutrition-based products, acquired Orgain Company, a plant-based nutrition-based company. In this agreement, Nestle would be able to expand the reach of the company Orgain Nutrition Products i.e. plant-based nutrition products, worldwide.

Figure 2. Canada Clinical Nutrition Market Value (US $ Mn), 2018-2030

To learn more about this report, request sample copy

Canada Clinical Nutrition Market– Impact of Coronavirus (COVID-19) Pandemic

• The COVID-19 pandemic is expected to have a positive effect on the Canada clinical nutrition market due to a significant increase in the prevalence of cancer in Canada during the COVID-19 pandemic. For instance, cancer patients often experience significant involuntary weight loss and malnutrition due to the disease itself and side effects of treatments such as chemotherapy and radiotherapy. Nutritional deficiencies further weaken the immune system and negatively impact treatment outcomes and recovery for cancer patients. According to a 2021 report by the Canadian Cancer Society, over 200,000 Canadians are diagnosed with cancer each year. With such a high prevalence rate, cancer patients often require customized clinical nutrition formulas and supplements to support their nutritional needs during treatment and recovery.
• Furthermore, the rising prevalence of diabetes, especially type 2 diabetes, is also expected to increase the growth of the Canada clinical nutrition market over the forecast period. Statistics published by the Public Health Agency of Canada (PHAC) indicate that in 2021, over 3.5 million Canadians aged 1 and older were diagnosed with diabetes. Further, the number of diabetes cases is expected to continue increasing over the next decade due to rising obesity rates and an aging population. Diabetes clinical nutrition products help manage blood sugar levels and energy intake, thereby preventing complications associated with improper glycemic control. The COVID-19 pandemic has led to increased health consciousness as well, prompting more diabetic Canadians to closely monitor their diet and rely on specialized nutrition formulas.

Canada Clinical Nutrition Market Segmentation:

The Canada clinical nutrition market report is segmented by nutrition type, by form, by route of administration, by age group, by application,  by end user, and by region.

• By nutrition type, the market is segmented into enteral nutrition and parenteral nutrition. Out of which, the enteral nutrition is expected to hold a dominant position in the Canada clinical nutrition market during the forecast period, as reported by Health Canada, 2021, over 650,000 Canadians receive tube feeding each year through enteral nutrition methods such as feeding tubes.
• By form, the market is segmented into powder, liquid, tablets, capsules, gummies and others (nutrition bar, among others). Out of which, powder is the dominant segment. As Powders are highly portable and can be easily mixed into beverages or other foods. This gives powders an advantage over other forms when it comes to compliance and consumption outside the home.
• By route of administration, the market is segmented into oral, enteral, and parenteral. Out of which, oral is expected to dominate the market over the forecast period, as for many patients, especially those with mild to moderate nutrition deficiencies, oral intake is the most natural and convenient option that does not require invasive medical procedures. This improves compliance and quality of life. Furthermore, oral supplements are easily administered at home or with a caregiver's assistance, reducing medical costs and freeing up resources within Canada's national healthcare system.
• By age group, the market is segmented into infant nutrition, adult nutrition and geriatric nutrition. Out of which, adult nutrition is expected to dominate the market over the forecast period, as according to 2021 data from Statistics Canada, adults between the ages of 20 and 64 make up over half of the country's population. With such a large adult demographic, it is unsurprising that clinical nutrition products designed for this life stage see the highest demand.
• By application, the market is segmented into diabetes, cancer, critical care, neurological disorders, metabolic syndrome, gastrointestinal diseases, and other (Cardiovascular Diseases and Others. Out of which, cancer is expected to dominate the market over the forecast period. As per statistics by the Canadian Cancer Society for 2020, over 200,000 Canadians are diagnosed with cancer each year. It is estimated that 1 in 2 Canadians will develop cancer in their lifetime. With such a high prevalence rate, the demand for specialized clinical nutrition to support cancer patients through their treatment and recovery process remains robust.
• By end user, the market is segmented into hospitals, ambulatory surgical centers, and long term care facilities. Out of which, hospitals is expected to dominate the market over the forecast period. Hospitals serve a large patient population across both inpatient and outpatient settings who often require specialized medical nutrition for various conditions such as cancer, gastrointestinal disorders, diabetes, and more.
• Among all the segmentation, the application segment is expected to dominate the market over the forecast period, and this is attributed to the increasing prevalence of chronic disorders among the Canadian population.

Canada Clinical Nutrition Market: Key Developments

• On November 1, 2022, Nestlé Health Sciences, a provider of nutrition products, completed the sale of the Gateway infant formula plant in Eau Claire, Wisconsin, along with U.S. and Canadian rights to the Gerber Good Start infant formula brand to Perrigo.
• In July 2022, Abbott Nutrition, a developer of innovative and science-based nutrition products, launched two new pediatric products: Pedialyte Electrolyte Therapy Drops and Pedialyte Gummies. These easy-to-ingest formulations provide essential hydration support for kids suffering from illnesses.

Canada Clinical Nutrition Market: Key Trends

• Increasing initiatives by the regulatory authority for the development of personalized nutrition products: Regulatory authorities are indulged in providing funding to inpatient and outpatient clinics for the development of personalized nutrition products. For instance, in January 2022, the National Institutes of Health (NIH) awarded US$ 170 million would be disbursed for a period of over five years to clinics and centers across the country for a new study that will develop algorithms to predict individual responses to food and dietary routines. Nutrition for Precision Health, powered by the All of Us Research Program (NPH), will recruit a diverse pool of 10,000 participants who are part of the NIH’s All of Us Research Program to inform more personalized nutrition recommendations. In this project, the NPH would take into consideration individual genetics, gut, microbes, and other factors such as lifestyle, biological, environmental, or social factors, etc.

Canada Clinical Nutrition Market: Restraint

• Stringent Regulatory Framework for New Product Approvals: Availability of stringent regulations in Canada is expected to restrain the Canada clinical nutrition market, over the forecast period. The clinical nutrition market in Canada is highly regulated by Health Canada, which ensures the safety and efficacy of nutrition products through a rigorous review and approval process for new entrants. Any small formulation changes to existing products also require re-approval. This stringent regulatory framework acts as a deterrent for smaller companies with limited resources to invest in clinical trials and navigate the complex approval process, which can take 1-2 years. The compliance burden and longer time-to-market delays restrain innovation and new product development in the Canada clinical nutrition market. In conclusion, while the aging population and rising chronic disease prevalence are driving demand growth factors, constraints around the high costs of products and stringent regulations present challenges to revenue and volume expansion in Canada’s clinical nutrition market. Innovation in formulations and manufacturing efficiencies will be key for companies to overcome pricing restraints.

Canada Clinical Nutrition Market - Key Players

Major players operating in the Canada clinical nutrition market include Nestle S.A.,  Abbott Laboratories,  Mead Johnson Nutrition Company,  Danone S.A.,  Bayer AG,  Fresenius Kabi AG,  Baxter International Inc.,  Cambrooke Therapeutics,  Vicore Pharma Holding AB,  Ajinomoto Cambrooke, Inc.,  Nutricia North America,  Vicore Pharma Holding AB,  Schatten Medical,  Otsuka Pharmaceutical and Vitaflo Asia-Pacific.

Definition: Clinical nutrition can be defined as the study and overall analysis of the relationship between ingested food and the overall wellbeing of the human body.